Elizabeth Lihua Budde, M.D., Ph.D.

  • Assistant Professor, Department of Hematology & Hematopoietic Cell Transplantation
  • Hematologic Oncologist

Elizabeth Lihua Budde, M.D., Ph.D.

Clinical Specialties
  • Hematology/Oncology
Research Focus
  • Immunotherapies for Leukemia and Lymphoma
Other Languages Spoken
  • English
  • Mandarin
Elizabeth Budde, M.D., Ph.D., is an assistant professor in the Department of Hematology & Hematopoietic Cell Transplantation at City of Hope. Dr. Budde's academic and clinical interests include investigating and designing novel means of immunotherapy for patients with lymphoma and leukemia, and she is part of the T Cell Therapeutics Research Laboratory, investigating the use of CAR T cells to treat blood cancers and other diseases.
 
Board certified in medical oncology and internal medicine, Dr. Budde has received many honors and awards for her work. She was chosen as a Special Fellow in Clinical Research awardee by the Leukemia & Lymphoma Society, a recipient of the Edson Immunotherapy Pilot Award from the J. Orin Edson Foundation and an awardee of the Stop Cancer Foundation seed grant in 2016. She is also a recipient of the prestigious Damon Runyon Cancer Research Foundation Clinical Investigator Award (2014-2017). She has served as the principal investigator on several innovative translational research protocols and has published her work in many peer-reviewed journals, and given presentations at national and international meetings.
  • 2013-Present, staff physician and assistant professor, Department of Hematologic Oncology & Hematopoietic Cell Transplantation
  • 2009-2013, Acting Instructor, Department of Medicine, University of Washington, Seattle, Washington
  • 2009-2013, Attending Physician, Hematopoietic Cell Transplant Service, Seattle Cancer Care Alliance, Seattle, Washington
  • 2009-2013, Attending Physician, Lymphoma Clinic, Seattle Cancer Care Alliance, Seattle, Washington
  • Leukemia
  • Lymphoma
  • Hematologic Cancers

Duarte

City of Hope Comprehensive Cancer Center, 1500 East Duarte Road, Duarte, CA, 91010

Get Directions

Phone :  626-256-4673

Degrees

  • 2001, M.D., Ph.D., Duke University of Medicine, Durham, NC
  • 1995, Bachelor of Medicine, Tongji Medical University Wuhan, Hubei, China

Fellowship

  • 2006 - 2009, University of Washington/ Fred Hutchinson Cancer Research Center, Seattle, WA

Residency

  • 2004 - 2006, Washington University School of Medicine, St. Louis, MO

Internship

  • 2003 - 2004, Intern, Internal Medicine, Washington University School of Medicine, St. Louis, MO
  • Medical Oncology
  • Internal Medicine
  • Mantle Cell Lymphoma Consortium, Lymphoma Research Foundation
  • American Society of Hematology, Member
  • American Society of Clinical Oncology
  • Chinese American Faculty Association in Southern California (President, 2016)
  • 2016, Greg Wiviott and Sharon & Robert Wiviott Seed grant, Stop Cancer Foundation
  • 2014-2017, Clinical investigator, Damon Runyon Cancer Research Foundation
  • 2014-2016, Tim Nesvig Lymphoma Research Foundation Fellow
  • 2013-2016, Awardee, Developmental Research Program, City of Hope Lymphoma SPORE (P50 CA 107399)
  • 2013-2016, Awardee, Career Enhancement Program, City of Hope Lymphoma SPORE
  • 2013-2015, Margaret E. Early Medical Trust Fund
  • 2013, Tower Cancer Foundation Research Grant
  • 2010-2012, Edson Immunotherapy Pilot Award
  • 2009-2012, Special Fellow in Clinical Research, Leukemia & Lymphoma Society
  • 2009, Participant, AACR/ASCO Workshop in Clinical Cancer Research
  • 2008, Participant, The 13th Annual NCCN Fellow Recognition Program
  • 2007, Participant, AACR Workshop on Molecular Biology in Clinical Oncology Workshop
  • 2005, Best Poster Presentation in Research Category for Medical Residents, American College of Physicians, Missouri Chapter Annual Meeting
  • 1999, Graduate Student Travel Award, B Cell Biology, Keystone International Meeting
  • 1997-2000, Research Assistantship, Duke University
  • 1995-1997, Graduate School Fellowship, Duke University
  • 1995, Graduation with Highest Honors, Tongji Medical University
Back To Top